Literature DB >> 14705981

The structural basis of T-cell allorecognition.

A Whitelegg1, L D Barber.   

Abstract

Foreign allogeneic major histocompatibility complex (MHC) class I and class II molecules elicit an exceptionally vigorous T-cell response. A small component of the alloresponse comprises CD4+ T cells that recognize allogeneic MHC indirectly after processing into peptide fragments that are bound and presented by self-MHC class II. The majority of alloreactive T cells directly recognize intact allogeneic MHC molecules expressed on foreign cells. Some alloreactive T-cell interactions with allogeneic MHC molecules are indifferent to the bound peptide, but evidence suggests that most show specificity to peptide. The vigor and diversity of the direct alloreactive T-cell response can therefore be explained by summation of numerous responses to each of the peptides in the novel set bound by allogeneic MHC molecules. Structural studies definitively show that the overall mechanism of T-cell receptor (TCR) recognition of self-MHC and allogeneic MHC molecules is similar. Many alloreactive T cells recognize several different combinations of MHC and bound peptide that do not necessarily possess structural homology. Flexibility within the TCR structure allows adaptation to the different contact surfaces. Crossreactivity seems to be an intrinsic property of the TCR required, because a single TCR must possess the ability to interact with both self-MHC during positive selection and at least one combination of foreign antigenic peptide presented by self-MHC. Recognition of allogeneic MHC molecules is an inadvertent consequence of the need for TCR crossreactivity.

Mesh:

Substances:

Year:  2004        PMID: 14705981     DOI: 10.1111/j.1399-0039.2004.00188.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

1.  A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.

Authors:  Qian Yu; Li Zhang; Lichen Ouyang; Yeli Gong; Zhihui Liang; Guanxin Shen; Xiufang Weng; Xiongwen Wu
Journal:  Immunogenetics       Date:  2012-12-12       Impact factor: 2.846

Review 2.  Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

Authors:  Pawel Muranski; Andrea Boni; Claudia Wrzesinski; Deborah E Citrin; Steven A Rosenberg; Richard Childs; Nicholas P Restifo
Journal:  Nat Clin Pract Oncol       Date:  2006-12

3.  Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs.

Authors:  Iryna A Isakova; Jason Dufour; Calvin Lanclos; Julie Bruhn; Donald G Phinney
Journal:  Exp Hematol       Date:  2010-07-01       Impact factor: 3.084

4.  Modulation of human peripheral blood mononuclear cell proliferative response by diltiazem : in vitro comparison in younger versus older subjects.

Authors:  Antonella D'Ambrosio; Luciana Giordani; Manuela Colucci; Nicola Vanacore; Francesca Quintieri
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  Failure of effector function of human CD8+ T Cells in NOD/SCID/JAK3⁻/⁻ immunodeficient mice transplanted with human CD34+ hematopoietic stem cells.

Authors:  Yoshinori Sato; Hiroshi Takata; Naoki Kobayashi; Sayaka Nagata; Naomi Nakagata; Takamasa Ueno; Masafumi Takiguchi
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

6.  Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation.

Authors:  S R Marino; S Lin; M Maiers; M Haagenson; S Spellman; J P Klein; T A Binkowski; S J Lee; K van Besien
Journal:  Bone Marrow Transplant       Date:  2011-03-28       Impact factor: 5.483

Review 7.  TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition.

Authors:  L J D'Orsogna; D L Roelen; I I N Doxiadis; F H J Claas
Journal:  Immunogenetics       Date:  2011-12-03       Impact factor: 2.846

Review 8.  The HLA system: genetics, immunology, clinical testing, and clinical implications.

Authors:  Sung Yoon Choo
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

9.  The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein.

Authors:  Maria T Rodriguez-Plata; Isabel Puigdomènech; Nuria Izquierdo-Useros; Maria C Puertas; Jorge Carrillo; Itziar Erkizia; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Retrovirology       Date:  2013-04-16       Impact factor: 4.602

Review 10.  A critical analysis of rejection in vascularized composite allotransplantation: clinical, cellular and molecular aspects, current challenges, and novel concepts.

Authors:  Karim A Sarhane; Sami H Tuffaha; Justin M Broyles; Amir E Ibrahim; Saami Khalifian; Pablo Baltodano; Gabriel F Santiago; Mohammed Alrakan; Zuhaib Ibrahim
Journal:  Front Immunol       Date:  2013-11-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.